A British cancer patient astonished doctors when 70 potentially lethal tumors disappeared from his body in just twelve weeks.
In 2001, 47-year-old Ian Brooks manifested a rare form of non-Hodgkin’s lymphoma – a type of cancer that attacks the immune system. The treatments effectively fought the disease then, but in 2008, cancer reappeared in a more aggressive manner than ever.
The checkups revealed 60-70 scattered cancer tumors from the head to the abdomen and the doctors said he had a few weeks to live. The last resort was to test an experimental drug of that time, which was gladly accepted by Brooks, since
“if he did nothing, his death would be a matter of weeks.”
However, 12 weeks later, doctors at the Christie Hospital in Manchester discovered with surprise that the experimental drug had cleared the body from all tumors.
The drug Mr. Brooks took is called Brentuximab vedotin and is a type of monoclonal antibody approved in the U.S. and Europe in 2011 and 2012 respectively. The drug is approved to treat Hodgkin lymphoma and a rare type of lymphoma – the so-called anaplastic large cell lymphoma.
According to the press release, the response of Mr. Brooks to the drug was such that his doctor, Dr. Adam Gibbs, said the tests before and after taking the drug “were probably the most impressive set of tests he has never seen.”
Mr. Brooks is currently in remission, and his doctors are optimistic about the state of his health.
“I feel like someone is watching over me because after all these treatments and the tumors I had, I’m still here,” he said.
With the terrifying prevalence of cancer, reading about new promising treatments is refreshing. Reports such as this one give us hope that one day, it will be possible to successfully treat even the potentially lethal forms of cancer.
View Comments
Thanks for posting this informative and great blog and i really appreciate your work, Finally i have understand something about cbd oil. It helps me to understand the better use of it in real life.
Appreciate Your Effort. Incredible points. Solid arguments. Keep up the amazing work.